Cargando…
Assessment of serological responses following vaccination campaigns with type 2 novel oral polio vaccine: a population-based study in Tajikistan in 2021
BACKGROUND: Novel oral poliovirus vaccine type 2 (nOPV2) was used to control an outbreak of type 2 circulating vaccine derived poliovirus (cVDPV2) in Tajikistan, in 2021. We measured seroconversion and seroprevalence of type 2 polio antibodies in children who were reported to have received two doses...
Autores principales: | Mirzoev, Azamdzhon, Macklin, Grace R, Zhang, Yiting, Mainou, Bernardo A, Sadykova, Umeda, Olsavszky, Victor Stefan, Huseynov, Shahin, Ruziev, Murodali, Saidzoda, Faizali, Bobokhonova, Mahtob, Mach, Ondrej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681660/ https://www.ncbi.nlm.nih.gov/pubmed/36400086 http://dx.doi.org/10.1016/S2214-109X(22)00412-0 |
Ejemplares similares
-
Notes from the Field: Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived Poliovirus Outbreak — Tajikistan, 2020–2021
por: O’Connor, Patrick, et al.
Publicado: (2022) -
What Led to the Nigerian Boycott of the Polio Vaccination Campaign?
por: Jegede, Ayodele Samuel
Publicado: (2007) -
Improving polio vaccination during supplementary campaigns at areas of mass transit in India
por: Shah, Naman K, et al.
Publicado: (2010) -
Mandatory vaccination: understanding the common good in the midst of the global polio eradication campaign
por: Gostin, Lawrence O.
Publicado: (2018) -
Campaigns with oral polio vaccine may lower mortality and create unexpected results
por: Benn, C.S., et al.
Publicado: (2017)